Company · CIK 0001145460 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances
ALERE INC. · ALR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2015 SForm 4 → | Jun 2, 5:07 pm EDT | John BridgenSr VP, Business Develop | 7,500 | $51.19 | $383,933 | 4,552 | −62.2% | plan? |
| Jun 1, 2015 MForm 4 → | Jun 2, 5:07 pm EDT | John BridgenSr VP, Business Develop | 7,500 | $26.06 | $195,450 | 12,052 | — | plan? |
| May 29, 2015 SForm 4 → | Jun 2, 5:07 pm EDT | John BridgenSr VP, Business Develop | 22,564 | $51.17 | $1,154,487 | 4,552 | −83.2% | plan? |
| May 29, 2015 MForm 4 → | Jun 2, 5:07 pm EDT | John BridgenSr VP, Business Develop | 22,564 | $35.58 | $802,827 | 27,116 | — | plan? |
| May 22, 2015 FMForm 4 → | May 27, 4:48 pm EDT | John QuelchDirector | 38,659 | $36.25 | $1,401,457 | 21,121 | — | plan? |
| May 13, 2015 FMForm 4/A → | Apr 12, 2016, 3:08 pm EDT | Carol R GoldbergDirector | 39,076 | $35.86 | $1,401,453 | 35,084 | — | plan? |
| May 13, 2015 FMForm 4 → | May 15, 5:07 pm EDT | Carol R GoldbergDirector | 39,076 | $35.86 | $1,401,453 | 10,924 | — | plan? amended |
| Apr 30, 2015 SForm 4 → | May 4, 4:58 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 3,031 | $47.81 | $144,912 | 0 | −100% | plan? |
| Apr 30, 2015 MForm 4 → | May 4, 4:58 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 3,031 | $25.68 | $77,836 | 3,031 | — | plan? |
| Apr 20, 2015 FMForm 4 → | Apr 22, 8:32 pm EDT | John F LevyDirector | 39,000 | $35.93 | $1,401,450 | 158,125 | — | plan? |
| Apr 6, 2015 SForm 4 → | Apr 8, 7:53 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 2,500 | $50.00 | $125,000 | 0 | −100% | plan? |
| Apr 6, 2015 MForm 4 → | Apr 8, 7:53 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 2,500 | $33.73 | $84,325 | 2,500 | — | plan? |
| Mar 23, 2015 SForm 4 → | Mar 25, 4:38 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 13,476 | $48.35 | $651,497 | 0 | −100% | plan? |
| Mar 23, 2015 MForm 4 → | Mar 25, 4:38 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 13,476 | $20.33 | $273,993 | 13,476 | — | plan? |
| Mar 17, 2015 SForm 4 → | Mar 19, 4:35 pm EDT | John BridgenSr VP, Business Develop | 25,000 | $48.53 | $1,213,250 | 4,552 | −84.6% | plan? |
| Mar 17, 2015 MForm 4 → | Mar 19, 4:35 pm EDT | John BridgenSr VP, Business Develop | 25,000 | $42.26 | $1,056,500 | 29,552 | — | plan? |
| Mar 16, 2015 SForm 4/A → | Apr 16, 9:53 am EDT | Carla FlakneVP, Chief Accounting Officer | 8,500 | $48.99 | $416,449 | 3,252 | −72.3% | plan? |
| Mar 16, 2015 MForm 4/A → | Apr 16, 9:53 am EDT | Carla FlakneVP, Chief Accounting Officer | 8,500 | $38.79 | $329,730 | 11,752 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 6:20 pm EDT | Carla FlakneVP, Chief Accounting Officer | 8,500 | $48.99 | $416,449 | 0 | −100% | plan? amended |
| Mar 16, 2015 MForm 4 → | Mar 18, 6:20 pm EDT | Carla FlakneVP, Chief Accounting Officer | 8,500 | $38.79 | $329,730 | 8,500 | — | plan? amended |
| Feb 23, 2015 SForm 4 → | Feb 25, 4:54 pm EST | Mark GladwellSenior VP, Global Operations | 13,292 | $44.62 | $593,036 | 0 | −100% | plan? |
| Feb 23, 2015 MForm 4 → | Feb 25, 4:54 pm EST | Mark GladwellSenior VP, Global Operations | 12,500 | $28.03 | $350,375 | 13,292 | — | plan? |
| Jan 16, 2015 SForm 4/A → | Apr 27, 2016, 5:21 pm EDT | Carla FlakneVP, Chief Accounting Officer | 10,000 | $42.45 | $424,450 | 3,714 | −72.9% | plan? |
| Jan 16, 2015 SForm 4 → | Jan 20, 4:10 pm EST | Carla FlakneVP, Chief Accounting Officer | 10,000 | $42.45 | $424,450 | 3,252 | −75.5% | plan? amended |
| Jan 13, 2015 SForm 4/A → | Apr 12, 2016, 3:07 pm EDT | Carol R GoldbergDirector | 110 | $39.46 | $4,341 | 40,024 | −0.27% | plan? |
| Jan 13, 2015 GForm 4 → | May 15, 5:06 pm EDT | Carol R GoldbergDirector | 4,378 | — | — | 0 | — | plan? late amended |
| Jan 13, 2015 SForm 4 → | May 15, 5:06 pm EDT | Carol R GoldbergDirector | 110 | $39.46 | $4,341 | 0 | −100% | plan? late amended |
| Dec 30, 2014 MForm 4 → | Jan 2, 2015, 1:52 pm EST | Namal NawanaChief Executive Officer, Director | 5,000 | — | — | 5,903 | — | plan? |
| Nov 7, 2014 GMForm 4 → | Jan 20, 2015, 4:10 pm EST | Carla FlakneVP, Chief Accounting Officer | 10,380 | $23.15 | $231,500 | 13,252 | — | plan? late amended |
| Jun 30, 2014 JForm 5 → | Feb 17, 2015, 9:40 am EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 270 | $31.48 | $8,499 | 3,751 | — | plan? |
| Jun 30, 2014 JForm 5 → | Feb 17, 2015, 9:40 am EST | Daniella CrampGlobal Pres., Cardiometabolic | 662 | $31.45 | $20,821 | 6,175 | — | plan? |
| Jun 30, 2014 JForm 5 → | Feb 17, 2015, 9:40 am EST | Dave TeitelChief Financial Officer | 405 | $31.47 | $12,747 | 5,201 | — | plan? |
| Jun 30, 2014 JForm 5 → | Feb 17, 2015, 9:39 am EST | Sanjay MalkaniGlobal Pres., Toxicology | 662 | $31.45 | $20,821 | 6,222 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2015 MForm 4 → | Jun 10, 5:03 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 24,331 | — | — | 25,000 | — | |
| Jun 4, 2015 MForm 4 → | Jun 8, 4:48 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 15,669 | — | — | 44,331 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 5:07 pm EDT | John BridgenSr VP, Business Develop | 7,500 | — | — | 0 | — | |
| May 29, 2015 MForm 4 → | Jun 2, 5:07 pm EDT | John BridgenSr VP, Business Develop | 22,564 | — | — | 0 | — | |
| May 22, 2015 MForm 4 → | May 27, 4:48 pm EDT | John QuelchDirector | 25,000 | — | — | 0 | — | |
| May 13, 2015 MForm 4 → | May 15, 5:07 pm EDT | Carol R GoldbergDirector | 25,000 | — | — | 0 | — | amended |
| Apr 30, 2015 AForm 4 → | May 4, 5:00 pm EDT | James F. HinrichsExecutive VP, CFO | 108,118 | — | — | 108,118 | — | |
| Apr 30, 2015 MForm 4 → | May 4, 4:58 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 3,031 | — | — | 0 | — | |
| Apr 20, 2015 MForm 4 → | Apr 22, 8:32 pm EDT | John F LevyDirector | 25,000 | — | — | 0 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 5:24 pm EDT | James F. HinrichsExecutive VP, CFO | 50,000 | — | — | 50,000 | — | |
| Apr 6, 2015 AForm 4 → | Apr 8, 7:53 pm EDT | James F. HinrichsExecutive VP, CFO | 250,000 | — | — | 250,000 | — | |
| Apr 6, 2015 MForm 4 → | Apr 8, 7:53 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 2,500 | — | — | 0 | — | |
| Mar 23, 2015 MForm 4 → | Mar 25, 4:38 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 13,476 | — | — | 0 | — | |
| Mar 17, 2015 MForm 4 → | Mar 19, 4:35 pm EDT | John BridgenSr VP, Business Develop | 25,000 | — | — | 0 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 6:20 pm EDT | Carla FlakneVP, Chief Accounting Officer | 8,500 | — | — | 0 | — | amended |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:48 pm EST | Namal NawanaChief Executive Officer, Director | 300,000 | — | — | 300,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:48 pm EST | Dave TeitelChief Financial Officer | 35,000 | — | — | 35,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:47 pm EST | Avi PelossofGlobalPres, Infectious Disease | 45,000 | — | — | 45,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:47 pm EST | Robert Bernard HargadonSVP, Global Human Resources | 35,000 | — | — | 35,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:47 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 45,000 | — | — | 45,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:47 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 35,000 | — | — | 35,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:47 pm EST | John BridgenSr VP, Business Develop | 35,000 | — | — | 35,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:47 pm EST | Mark GladwellSenior VP, Global Operations | 35,000 | — | — | 35,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:46 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 35,000 | — | — | 35,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:46 pm EST | Renuka UppaluriSenior VP, Global R&D | 95,000 | — | — | 20,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:46 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 45,000 | — | — | 45,000 | — | |
| Feb 28, 2015 AForm 4 → | Mar 3, 4:46 pm EST | Carla FlakneVP, Chief Accounting Officer | 20,000 | — | — | 20,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:20 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 5,000 | — | — | 5,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:47 pm EST | John BridgenSr VP, Business Develop | 750 | — | — | 750 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:47 pm EST | Dave TeitelChief Financial Officer | 750 | — | — | 750 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:47 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 1,750 | — | — | 250 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:46 pm EST | Avi PelossofGlobalPres, Infectious Disease | 5,000 | — | — | 5,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:46 pm EST | Mark GladwellSenior VP, Global Operations | 2,500 | — | — | 2,500 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:46 pm EST | Robert Bernard HargadonSVP, Global Human Resources | 1,250 | — | — | 1,250 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:46 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 3,375 | — | — | 3,375 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:46 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 1,250 | — | — | 1,250 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 4:46 pm EST | Carla FlakneVP, Chief Accounting Officer | 1,012 | — | — | 1,012 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 4:54 pm EST | Mark GladwellSenior VP, Global Operations | 12,500 | — | — | 0 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 9:06 am EST | Namal NawanaChief Executive Officer, Director | 150,000 | — | — | 150,000 | — | |
| Jan 16, 2015 MForm 4 → | Jan 20, 4:10 pm EST | Carla FlakneVP, Chief Accounting Officer | 10,000 | — | — | 0 | — | amended |
| Dec 30, 2014 MForm 4 → | Jan 2, 2015, 1:52 pm EST | Namal NawanaChief Executive Officer, Director | 5,000 | — | — | 100,000 | — |